{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:57:24Z","timestamp":1793912244423,"version":"4.8.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1097\/tp.0000000000001329","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T15:21:11Z","timestamp":1468509671000},"page":"1468-1472","source":"Crossref","is-referenced-by-count":39,"title":["Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates"],"prefix":"10.1097","volume":"101","author":[{"given":"Jacques","family":"Simkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Margarita","family":"Abbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Fernando","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Ileana","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-47-20210211","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/427692","article-title":"Mycobacterium tuberculosis infection in recipients of solid organ transplants","volume":"40","author":"Mu\u00f1oz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R3-47-20210211","first-page":"498","article-title":"Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results","volume":"12","author":"Menzies","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R4-47-20210211","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ajt.12100","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation","volume":"13","author":"Subramanian","year":"2013","journal-title":"Am J Transplant"},{"key":"R5-47-20210211","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R6-47-20210211","first-page":"341","article-title":"Tuberculosis in California dialysis patients","volume":"8","author":"Ahmed","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"R7-47-20210211","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"R8-47-20210211","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"R9-47-20210211","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","article-title":"Clinical practice. Latent tuberculosis infection in the United States","volume":"364","author":"Horsburgh","year":"2011","journal-title":"N Engl J Med"},{"key":"R10-47-20210211","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/TP.0b013e3182a94a2f","article-title":"Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates","volume":"97","author":"de Castilla","year":"2014","journal-title":"Transplantation"},{"key":"R11-47-20210211","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.","volume":"60","year":"2011","journal-title":"Morb Mortal Wkly Rep"},{"key":"R12-47-20210211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"key":"R13-47-20210211","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.5588\/ijtld.13.0423","article-title":"Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States","volume":"17","author":"Shepardson","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"R14-47-20210211","doi-asserted-by":"crossref","first-page":"e22276","DOI":"10.1371\/journal.pone.0022276","article-title":"Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection","volume":"6","author":"Holland","year":"2011","journal-title":"PLoS One"},{"key":"R15-47-20210211","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/tmj.2010.0164","article-title":"Text messaging for enhancement of testing and treatment for tuberculosis, human immunodeficiency virus, and syphilis: a survey of attitudes toward cellular phones and healthcare","volume":"17","author":"Person","year":"2011","journal-title":"Telemed J E Health"},{"key":"R16-47-20210211","doi-asserted-by":"crossref","first-page":"e004362","DOI":"10.1136\/bmjopen-2013-004362","article-title":"The effect of weekly text-message communication on treatment completion among patients with latent tuberculosis infection: study protocol for a randomised controlled trial (WelTel LTBI)","volume":"4","author":"van der Kop","year":"2014","journal-title":"BMJ Open"},{"key":"R17-47-20210211","first-page":"1","article-title":"American Thoracic Society.","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"R18-47-20210211","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archinte.162.9.1044","article-title":"Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail","volume":"162","author":"White","year":"2002","journal-title":"Arch Intern Med"},{"key":"R19-47-20210211","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/00007890-199705150-00015","article-title":"Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA","volume":"63","author":"Aguado","year":"1997","journal-title":"Transplantation"},{"key":"R20-47-20210211","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jval.2011.05.003","article-title":"Patient preference for latent tuberculosis infection preventive treatment: a discrete choice experiment","volume":"14","author":"Guo","year":"2011","journal-title":"Value Health"},{"key":"R21-47-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2012.747952","article-title":"Update on rifampin, rifabutin, and rifapentine drug interactions","volume":"29","author":"Baciewicz","year":"2013","journal-title":"Curr Med Res Opin"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:24:45Z","timestamp":1620977085000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201706000-00047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001329","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}